Modern Oral net sales more than doubled year-over-year, now nearly half of total sales, while overall net income and adjusted EBITDA declined due to heavy investment in sales and marketing. Full-year guidance for Modern Oral and adjusted EBITDA was raised, supported by strong liquidity and equity f…
Modern Oral net sales more than doubled year-over-year, now nearly half of total sales, while overall net income and adjusted EBITDA declined due to heavy investment in sales and marketing. Full-year guidance for Modern Oral and adjusted EBITDA was raised, supported by strong liquidity and equity financing.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
